Introduction
The brain and testis are highly protected from the invasion of xenobiotic compounds by the blood-brain barrier (BBB) and blood-testis barrier (BTB). The BBB is formed by brain microvascular endothelial cells, while myoid and Sertoli cells are involved in the BTB in addition to the endothelial cells (Bart et al., 2002; Kusuhara and Sugiyama, 2005; Scherrmann, 2005) . In addition to the highly developed tight junctions between adjacent cells, the BBB and BTB express multiple xenobiotic transporters characterized by broad substrate specificities.
They actively extrude xenobiotic compounds into the circulating blood and, thereby, limit tissue penetration from the circulating blood. On the luminal side of the BBB, ABC transporters, such as P-glycoprotein (P-gp/MDR1/ABCB1), multidrug resistance-associated protein 1 (MRP1/ABCC1) and -4 (MRP4/ABCC4), and breast cancer resistance protein (BCRP/ABCG2), are expressed (Schinkel, 1999; Leggas et al., 2004; Lee et al., 2005; Leslie et al., 2005; Scherrmann, 2005) . Among them, P-gp is the best characterized transporter providing a barrier function for the BBB. Cumulative studies have shown that it plays a key role in limiting the penetration of a variety of drugs and toxins (Schinkel, 1999; Scherrmann, 2005) .
Immunohistochemical analysis has demonstrated the expression of P-gp, MRP1, and BCRP in the BTB (Bart et al., 2004; Augustine et al., 2005) . In vivo studies using Mdr1a -/or Mrp1 -/mice have shown their roles in protecting the testis from invasion by their substrates (Wijnholds This article has not been copyedited and formatted. The final version may differ from this version. the transport activities of the compounds by mouse Bcrp and the increase in their tissue-to-plasma concentration ratios. Adachi et al. (2001) and Yamazaki et al. (2001) previously demonstrated that the corrected flux ratio (CFR), obtained by the ratio of the basal-to-apical and apical-to-basal transport across the monolayers of epithelial cells expressing P-gp divided by the corresponding ratio in mock cells, is a good predictor of in vivo P-gp activity at the BBB (Adachi et al., 2001; Yamazaki et al., 2001) . In addition to phytoestrogens (Enokizono et al., 2007b) , we investigated the effect of BCRP on the brain and testicular distribution of five compounds, including dietary carcinogens [2-amino-3,8-dimethylimidazo[4,5-f ]quinoxaline (MeIQx) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and drugs (dantrolene, prazosin and triamterene), using Bcrp -/mice. Transcellular transport of the compounds across the monolayers of MDCK cells expressing mouse Bcrp was also determined. The CFR for Bcrp was not a good predictor of the increase in K p values in the brain and testis in Bcrp -/mice. It was also found that some Bcrp substrates, particularly those exhibiting a marginal increase in K p values, are also P-gp substrates. The present study proposes that Bcrp plays a significant role in limiting the tissue penetration of xenobiotic compounds, but the impact of functional impairment of Bcrp is also modulated by P-glycoprotein activity on their shared substrates. were also measured in addition to that of the parent form. Kp , brain and Kp ,testis were obtained by dividing the brain and testis concentrations by the plasma concentrations at the last sampling point (Adachi et al., 2001) .
In situ brain perfusion
In situ brain perfusion was carried out according to the previous report by Dagenais et al. (Dagenais et al., 2000) . Briefly, mice were anesthetized by i.p. injection of pentobarbital sodium (50 mg/kg), and the right common carotid artery was catheterized with a polyethylene tube (PE-10) mounted on a 30-gauge needle. Before insertion of the catheter, the common carotid artery was ligated caudally. During surgery, the body temperature was maintained on a heated plate. The syringe containing the perfusion fluid was placed in an infusion pump (Packard Instruments, Meriden, CT) and connected to the catheter. Before perfusion, the thorax of the animal was opened, the heart was cut, and perfusion was started immediately at a flow warmed to 37 °C in a water bath. The concentration of the test compounds was 5 µM. The one-minute perfusion was terminated by decapitation. The brain was then removed, and the cortex of the right cerebral hemisphere was collected and weighed.
Calculation of initial uptake clearance
The average vascular volume (V vasc ) following brain perfusion is reported to be 10 µL/g brain (Dagenais et al., 2000) . This value was used to correct for vascular contamination in brain tissue. The initial uptake clearances of test compounds (CL up , µ L/min/g brain) were calculated using the following equation:
CL up = X brain /T/C perf where X brain is the compound in the right cortex (nmol/g brain) corrected for vascular contamination (X total -V vasc · C perf ), C perf is the concentration of compound in the perfusate (nmol/µL), and T is the perfusion time (min).
In vitro transport study
This article has not been copyedited and formatted. The final version may differ from this version. cells were subjected to the transport study on the fourth day. The procedures for the transport study were the same as those used for mouse Bcrp.
Efflux rates were calculated from the slopes of the time-profiles of the apical-to-basal and basal-to-apical transport. Flux ratios were obtained by dividing efflux rates in the basal-to-apical direction by those in the apical-to-basal direction. Flux ratios in transporterexpressing cells were divided by those in control cells to give a "corrected flux ratio (CFR) ".
CFR was used as the transport activity index.
Preparation of N-hydroxyl (N-OH) PhIP
After the administration of PhIP to rats, N-hydroxyl PhIP (N-OH PhIP) is excreted into the bile mainly in its glucuronide form (Dietrich et al., 2001) . Therefore, N-OH PhIP was purified from β -glucuronidase-treated bile obtained from rats that had been given PhIP. Under ether anesthesia, the bile duct was cannulated with a polyethylene tube (PE10) then PhIP was intraperitonealy administered at a dose of 100 mg/kg and bile was collected for 2.5 h. Bile was loaded onto a solid phase extraction cartridge (OASIS HLB; Waters, Milford, MA), which was then washed with water and eluted with acetonitrile. The eluted solution was evaporated, reconstituted in PBS containing 5 mM ascorbic acid and treated with β-glucuronidase (Roche, Basel, Switzerland) for 3 h at 37 °C. Ascorbic acid was added to prevent the autooxidation of N-OH PhIP. The reaction was stopped by adding a 30% volume of acetonitrile, and N-OH PhIP was purified by HPLC, using a D-7000 series instrument (Hitachi, Tokyo) equipped with an Inertsil ODS-2, 5 µ m, 4.6 mm I.D. x 250 mm column (GL Science, Tokyo, Japan). The mobile phase A was 10 mM ammonium acetate and the mobile phase B was acetonitrile. The mobile phase B concentration was 7% at 0 min and was then linearly increased to 20% over 60 min followed by a 5 min re-equilibration with the initial concentration. The flow rate was 1.2 mL/min, the column temperature was 40 °C and the detector wavelength was 313 nm. Under these conditions, PhIP and N-OH PhIP were eluted at 38.2 and 31.1 min, respectively. The purified N-OH PhIP was used to construct standard curves for the quantification of N-OH PhIP concentrations in plasma, brain and testis.
Quantification
Plasma samples were diluted with PBS to obtain 20% diluted plasma. This diluted plasma and 20% tissue homogenate were precipitated with 3-volumes of acetonitrile and centrifuged at 4 ºC, 15,000g for 10 min. The supernatants were evaporated, reconstituted in mobile phase and subjected to LC/MS(/MS) analysis. Aliquots obtained from in vitro transport studies were mixed with an equal volume of acetonitrile and centrifuged at 4 ºC and 15,000g for 10 min. The supernatants were diluted with an appropriate volume of mobile phase and Table 1 .
Statistical analysis
Statistical analysis of significant differences was performed using the two-tailed
Student's t test. A probability of <0.05 was considered to be statistically significant. were observed in Bcrp -/mice for dantrolene and daidzein ( Figure 3 ). The increase was 2.1-fold for dantrolene and 1.4-fold for daidzein. The CL up of PhIP was not significantly changed in
In vitro transport by mouse Bcrp and Mdr1a, and a comparison with in vivo data
Transcellular transport of the compounds was examined in polarized cell lines expressing Bcrp and Mdr1a where Bcrp and Mdr1a are localized in the apical membrane (Yamazaki et al., 2001; Matsushima et al., 2005) . In Bcrp-expressing cells, all the test compounds exhibited directional transport with statistically significant changes in the permeability ( Figure 4 and Table 2 ), indicating that all the compounds are Bcrp substrates. The comparison between K p ratios and CFR values in Bcrp-expressing cells is shown in Figure 5 and Table 3 . The data of three phytoestrogens were taken from our previous study (Enokizono et al., 2007b) . The relationships did not show any positive correlation ( Figure 5 ). Although PhIP, MeIQx, prazosin and triamterene exhibited large CFR values, the effect of functional impairment of Bcrp on the tissue concentration was marginal.
The time-profiles in the transcellular transport in Mdr1a-expressing cells are shown in Figure 6 and 
Discussion
In the present study, the effects of BCRP on the brain and testicular distribution of two dietary carcinogens and three drugs were investigated using Bcrp -/mice.
The increase in the K p values in the brain and testis in Bcrp -/mice compared with wild-type mice indicates that Bcrp limits both the brain and testicular distribution of MeIQx, PhIP, N-OH PhIP, dantrolene and prazosin. For triamterene, the K p, brain was significantly increased in Bcrp -/mice, while the K p, testis was increased but this was not statistically significant. For 4'-OH PhIP, K p, testis was significantly increased in Bcrp -/mice, while its brain concentration was below the limit of quantification and, thus, the impact of functional impairment of Bcrp on the K p, brain of 4-OH PhIP remains to be evaluated. In contrast, the impact of functional impairment of Bcrp on the uptake transport in the BBB was smaller than that observed on the K p values (Figure 3 ). Because the K p values determined under steady-state conditions represent the ratio of the clearance of uptake transport to that of efflux transport, it is likely that Bcrp mainly influences the efflux transport of its substrates in the BBB. The increase in the K p, brain of prazosin in Bcrp -/mice is consistent with a previous study in which the brain concentration of prazosin was increased by coadministration of GF120918 in Mdr1a -/mice (Cisternino et al., 2004) . The present results on PhIP contradict a previous study in which neither K p,brain nor K p,testis was changed (van Herwaarden et al., 2003) . This discrepancy can be Bcrp substrates with a greater CFR exhibited a somewhat smaller increase in K p values ( Figure   5 ). We assumed that this discrepancy is accounted for by the difference in the contribution of Bcrp to the net efflux at the BBB and BTB. Indeed, it was found that some Bcrp substrates are also P-gp substrates. In particular, the compounds exhibiting large increases in K p ratios were Bcrp-specific substrates. Therefore, it is likely that, for common substrates of Bcrp and P-gp, the impact of functional impairment of Bcrp on the K p values becomes smaller than predicted from the CFR because of active efflux mediated by P-gp. This will also account for the discrepancy reported previously that the brain distribution of some The four Bcrp-specific substrates are weak acids while the other compounds are basic or neutral at physiological pH (Table 3) . P-gp is well characterized by its preferential substrate recognition of lipophilic and basic compounds. BCRP also recognizes basic compounds, such as cimetidine and imatinib (Burger et al., 2004; Breedveld et al., 2005) , but it also accepts acidic compounds, such as methotrexate and sulfate conjugates (Volk et al., 2002; Suzuki et al., 2003) .
Based on the substrate specificity, it would be speculated that BCRP plays a major role in the efflux of acidic compounds in the BBB and BTB, but only a limited role in the efflux of basic compounds which are mainly extruded by P-gp. It should be noted that some MRPs have been identified in the BBB which accepts anionic compounds as substrates (Kusuhara et al., 1998; Zhang et al., 2000; Leggas et al., 2004) . Further studies are necessary to elucidate the role of N-hydroxylation is a bioactivation pathway for dietary carcinogens (Kim and Guengerich, 2005) .
Our results suggest that Bcrp accepts N-OH PhIP and, moreover, BCRP may limit DNA adduct formation in the brain and testis. The brain uptake for 1 min was determined by the in situ brain perfusion technique. CL up was obtained by subtracting the amount associated with the capillary space from that associated with brain specimens divided by the concentration in the infusate. CL up values in wild-type and 
Figure 5. Relationships between the in vitro transport activities and in vivo BCRP effects
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The transport activities of test compounds were estimated from the study using MDCK II cell monolayers expressing mouse Bcrp and expressed as corrected flux ratios (CFR). In vivo BCRP activities were evaluated by the ratio of K p values in wild-type and Bcrp -/mice. K p ratios were plotted against CFR. 1, PhIP; 2, MeIQx; 3, dantrolene; 4, prazosin; 5, triamterene; 6, daidzein; 7, genistein; 8, coumestrol. K p values and CFR of phytoestrogens were obtained from Enokizono et al., (2007) . Data were taken from Figure 4 and 6. Permeabilities were obtained from the slopes of the transcellular transport from 40 to 120 min, and the concentration in the donor compartment.
Asterisks represent statistically significant differences in the permeability between in transporter-expressing cells and the corresponding control cells; *P < 0.05 and **P < 0.01. 
